Enigmatic gene critical for a healthy brain
Francis Szele
Scientists from the Universities of Bath, Oxford and Edinburgh have now identified one such non-coding RNA, called Paupar, which influences how healthy brains develop during early life. They have shown that Paupar orchestrates proteins that control neurodevelopment.
They studied KAP1, a gene that codes for an essential protein associated with several fundamental processes in neurodevelopment. The KAP1 protein acts as a regulator for several other genes which allow the brain to grow healthily and develop several types of brain cell.
Using molecular biology techniques they discovered that Paupar can act as a switch, modulating how KAP1 acts by binding to it- thus influencing the development of healthy brains in mice. It is the first time that a non-coding RNA has been shown to bind to KAP1.
Dr Keith Vance, from the University of Bath Department of Biology & Biochemistry led the research. He said: "It is now clear that the genome expresses many non-coding RNAs that are not made into protein. Despite this, there is a lot of controversy regarding their function. Some groups argue that these non-coding RNAs are a result of transcriptional noise with no apparent use whilst others think that the vast majority of them must be doing something important.
"We have shown here good evidence that one of these genes, called Paupar, is important for development of the brain.
"It's a young field, but I think it's clear we have to reassess the central dogma of molecular biology that DNA is transcribed to RNA that codes for a protein. We're now seeing that some RNAs can go off and do something themselves.
"Our findings also help us understand the essential role of KAP1, which is something we're really interested in as we look at the development of the central nervous system."
Original publication
Most read news
Original publication
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.